drugset / Trial / NCT04333654
Hydroxychloroquine in Outpatient Adults With COVID-19
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Primary Objective: To assess the effect of hydroxychloroquine versus placebo on nasopharyngeal SARS-CoV-2 viral load in outpatient adults with COVID-19 Secondary Objectives: * To assess the effect of hydroxychloroquine versus placebo on clinical signs and symptoms and progression of disease in outpatient adults with COVID-19 * To assess the safety and tolerability of hydroxychloroquine in outpatient adults with COVID-19
Timeline
- Start
- 2020-04-12
- Primary completion
- 2020-05-26
- Completion
- 2020-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | — | Oral |